US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Ongoing

Amlodipine and Valsartan Tablets USP 5 mg/160 mg

Reason CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Aurobindo Pharma USA Inc. NDC 65862-737-30 D-0361-2019
Class II · Moderate risk Terminated

Estradiol Vaginal Inserts

Reason Defective Delivery System: Customer complaints of malfunctioning plunger of the applicator

Glenmark Pharmaceuticals Inc., USA NDC 68462-711-71 D-0350-2019
Class II · Moderate risk Terminated

Nitrofurantoin Oral Suspension

Reason Subpotent Drug: Expansion of June 2018 recall of lots S700065 and S700619 due to below specification results for assay.

Lupin Somerset NDC 43386-450-11 D-0346-2019
Class II · Moderate risk Ongoing

LOSARTAN POTASSIUM and HYDROCHLOROTHIAZIDE TABLETS

Reason CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Torrent Pharma Inc. D-0505-2019
Class II · Moderate risk Ongoing

LOSARTAN POTASSIUM and HYDROCHLOROTHIAZIDE TABLETS

Reason CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Torrent Pharma Inc. D-0504-2019
Class II · Moderate risk Ongoing

Losartan Potassium Tablets

Reason CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Torrent Pharma Inc. D-0503-2019
Class II · Moderate risk Ongoing

Losartan Potassium Tablets

Reason CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Torrent Pharma Inc. D-0502-2019
Class II · Moderate risk Ongoing

Losartan Potassium Tablets

Reason CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Torrent Pharma Inc. D-0501-2019
Class II · Moderate risk Completed

Ozurdex

Reason GMP Deviations: A silicone particulate was noted in Ozurdex.

Allergan, PLC. NDC 0023-3348-07 D-0387-2019
Class II · Moderate risk Terminated

Oxygen

Reason CGMP Deviations

Roberts Home Medical LLC D-1002-2019
Class II · Moderate risk Terminated

Cidofovir Dihydrate

Reason CGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.

LGM Pharma LLC D-0486-2019
Class II · Moderate risk Terminated

Folic Acid

Reason Lack of sterility assurance.

Promise Pharmacy, LLC D-0481-2019
Class II · Moderate risk Terminated

Zinc Sulfate

Reason Lack of sterility assurance.

Promise Pharmacy, LLC D-0480-2019
Class II · Moderate risk Terminated

Glycyrrhizic Acid

Reason Lack of sterility assurance.

Promise Pharmacy, LLC D-0479-2019
Class II · Moderate risk Terminated

Dexpanthenol

Reason Lack of sterility assurance.

Promise Pharmacy, LLC D-0478-2019
Class II · Moderate risk Terminated

Lysine HCl

Reason Lack of sterility assurance.

Promise Pharmacy, LLC D-0477-2019
Class II · Moderate risk Terminated

Pyridoxine HCl

Reason Lack of sterility assurance.

Promise Pharmacy, LLC D-0475-2019
Class II · Moderate risk Terminated

Procaine HCl

Reason Lack of sterility assurance.

Promise Pharmacy, LLC D-0474-2019
Class II · Moderate risk Terminated

Trim Calm

Reason Lack of sterility assurance.

Promise Pharmacy, LLC D-0473-2019
Class II · Moderate risk Terminated

Folic Acid

Reason Lack of sterility assurance.

Promise Pharmacy, LLC D-0472-2019
Class II · Moderate risk Terminated

Zinc Sulfate

Reason Lack of sterility assurance.

Promise Pharmacy, LLC D-0471-2019
Class II · Moderate risk Terminated

Myer's Cocktail

Reason Lack of sterility assurance.

Promise Pharmacy, LLC D-0470-2019
Class II · Moderate risk Terminated

Niacinamide injection

Reason Lack of sterility assurance.

Promise Pharmacy, LLC D-0469-2019